Nav1.7, its mutations, and the syndromes that they cause.
Waxman
Stephen G
SG
D001919:Bradycardia / Q000235:genetics / Q000503:physiopathology; D053447:Channelopathies / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D004916:Erythromelalgia / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D005483:Flushing / Q000235:genetics / Q000503:physiopathology; D005727:Ganglia, Spinal / Q000503:physiopathology; D005799:Genes, Dominant; D015640:Ion Channel Gating; D062556:NAV1.7 Voltage-Gated Sodium Channel; D009437:Neuralgia / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology; D010146:Pain / Q000503:physiopathology; D000699:Pain Insensitivity, Congenital / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology; D010641:Phenotype; D010812:Physical Stimulation; D015222:Sodium Channels / Q000235:genetics / Q000502:physiology*; D013564:Sympathetic Nervous System / Q000378:metabolism / Q000503:physiopathology; D013577:Syndrome
D062556:NAV1.7 Voltage-Gated Sodium Channel; C486866:SCN9A protein, human; D015222:Sodium Channels